Delivery Order SPE2DB22D2211-SPE2DB25FSFEW
- Not listed
- The Defense Logistics Agency awarded a $2,080.40 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albumin (Human) 25% Intravenous Solution, 50mL. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,255.80 delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Albumin (Human) 5% IV Solution in 250ml units. This is a firm fixed-price delivery order with a ceiling value of $1,506.96 and an ultimate completion date of October 16, 2025. The award was made on a competitive, non-set-aside basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, which maintains its corporate office at the place of...
- The Defense Logistics Agency (DLA) awarded a $2,296 delivery order to AmerisourceBergen Drug Corp for Human Albumin 5% intravenous solution in 250ml units. This firm fixed-price contract, awarded on August 4, 2025, with a completion date of August 25, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will be completed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child...
- The Defense Logistics Agency awarded a $7,300.30 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Albumin (Human) 25% Intravenous Solution in 50mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for completion by October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,498.32 for Human Albumin 25% intravenous solution in 100-milliliter units. Issued on August 25, 2025, with an ultimate completion date of September 16, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor for this...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Albumin (Human) 5% IV Solution in 250ml units, with a ceiling value of $1,506.96. This firm fixed-price delivery order is scheduled for completion by September 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml on June 16, 2025, with a ceiling value of $2,296.00 and ultimate completion date of July 9, 2025. This competitively awarded, firm fixed price delivery order was issued without a set-aside designation and will be performed in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albumin (Human) 25% Intravenous Solution 50ml, with a ceiling value of $2,816.10 and an ultimate completion date of September 29, 2025. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFEWDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,255.80 to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 5% Intravenous Solution in 250ml units. This is a firm fixed-price delivery order with an ultimate completion date of October 8, 2025, and was competitively awarded without set-aside restrictions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The broader SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for human albumin represents a routine pharmaceutical supply transaction within this strategic partnership to maintain critical medical commodities for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/17/25 |